284 related articles for article (PubMed ID: 19500128)
1. Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers.
Han SK; Kim HS; Kim WK
Dermatol Surg; 2009 Sep; 35(9):1342-8. PubMed ID: 19500128
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study.
Han SK; Choi KJ; Kim WK
Plast Reconstr Surg; 2004 Dec; 114(7):1783-9. PubMed ID: 15577349
[TBL] [Abstract][Full Text] [Related]
3. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.
Landsman AS; Cook J; Cook E; Landsman AR; Garrett P; Yoon J; Kirkwood A; Desman E
Foot Ankle Spec; 2011 Feb; 4(1):29-41. PubMed ID: 21135263
[TBL] [Abstract][Full Text] [Related]
4. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study.
You HJ; Han SK; Lee JW; Chang H
Wound Repair Regen; 2012; 20(4):491-9. PubMed ID: 22672334
[TBL] [Abstract][Full Text] [Related]
5. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers.
You HJ; Han SK; Rhie JW
J Wound Care; 2014 Nov; 23(11):521-2, 524, 526-30. PubMed ID: 25375400
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP
Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279
[TBL] [Abstract][Full Text] [Related]
8. Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients.
Cavallini M
Wound Repair Regen; 2007; 15(1):35-8. PubMed ID: 17244317
[TBL] [Abstract][Full Text] [Related]
9. A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers.
Moustafa M; Simpson C; Glover M; Dawson RA; Tesfaye S; Creagh FM; Haddow D; Short R; Heller S; MacNeil S
Diabet Med; 2004 Jul; 21(7):786-9. PubMed ID: 15209775
[TBL] [Abstract][Full Text] [Related]
10. Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage.
Puttirutvong P
J Med Assoc Thai; 2004 Jan; 87(1):66-72. PubMed ID: 14971537
[TBL] [Abstract][Full Text] [Related]
11. The cell based dressing with living allogenic keratinocytes in the treatment of foot ulcers: a case study.
Bayram Y; Deveci M; Imirzalioglu N; Soysal Y; Sengezer M
Br J Plast Surg; 2005 Oct; 58(7):988-96. PubMed ID: 16040019
[TBL] [Abstract][Full Text] [Related]
12. [Surgical strategy in treatment of diabetic foot].
Cen S; Huang F; Zhao J; Lu W; Wang C; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):803-6. PubMed ID: 18681279
[TBL] [Abstract][Full Text] [Related]
13. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
Saap LJ; Donohue K; Falanga V
Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
[TBL] [Abstract][Full Text] [Related]
14. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot.
Vojtassák J; Danisovic L; Kubes M; Bakos D; Jarábek L; Ulicná M; Blasko M
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():134-7. PubMed ID: 17159798
[TBL] [Abstract][Full Text] [Related]
15. Dermagraft in the treatment of diabetic foot ulcers.
Bowering CK
J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-29-32. PubMed ID: 10082605
[No Abstract] [Full Text] [Related]
16. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
[TBL] [Abstract][Full Text] [Related]
17. Apligraf in the treatment of neuropathic diabetic foot ulcers.
Edmonds M;
Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
[TBL] [Abstract][Full Text] [Related]
18. Radix Astragali and Radix Rehmanniae, the principal components of two antidiabetic foot ulcer herbal formulae, elicit viability-promoting effects on primary fibroblasts cultured from diabetic foot ulcer tissues.
Lau TW; Chan YW; Lau CP; Lau KM; Lau CB; Fung KP; Leung PC; Ho YY
Phytother Res; 2009 Jun; 23(6):809-15. PubMed ID: 19148881
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers.
Mohan VK
Diabetes Res Clin Pract; 2007 Dec; 78(3):405-11. PubMed ID: 17655964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
